Clinical management and impact of scarlet fever in the modern era: findings from a cross-sectional study of cases in London, 2018-2019.
epidemiology
microbiology
primary care
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
24 12 2021
24 12 2021
Historique:
entrez:
25
12
2021
pubmed:
26
12
2021
medline:
8
3
2022
Statut:
epublish
Résumé
In response to increasing incidence of scarlet fever and wider outbreaks of group A streptococcal infections in London, we aimed to characterise the epidemiology, symptoms, management and consequences of scarlet fever, and to identify factors associated with delayed diagnosis. Cross-sectional community-based study of children with scarlet fever notified to London's three Health Protection Teams, 2018-2019. From 2575 directly invited notified cases plus invitations via parental networks at 410 schools/nurseries with notified outbreaks of confirmed/probable scarlet fever, we received 477 responses (19% of those directly invited), of which 412 met the case definition. Median age was 4 years (range <1 to 16), 48% were female, and 70% were of white ethnicity. Preplanned measures included quantitative description of case demographics, symptoms, care-seeking, and clinical, social, and economic impact on cases and households. After survey completion, secondary analyses of factors associated with delayed diagnosis (by logistic regression) and consequences of delayed diagnosis (by Cox's regression), and qualitative analysis of free text comments were added. Rash was reported for 89% of cases, but followed onset of other symptoms for 71%, with a median 1-day delay. Pattern of onset varied with age: sore throat was more common at onset among children 5 years and older (OR3.1, 95% CI 1.9 to 5.0). At first consultation, for 28%, scarlet fever was not considered: in these cases, symptoms were frequently attributed to viral infection (60%, 64/106). Delay in diagnosis beyond first consultation occurred more frequently among children aged 5+ who presented with sore throat (OR 2.8 vs 5+without sore throat; 95% CI 1.3 to 5.8). Cases with delayed diagnosis took, on average, 1 day longer to return to baseline activities. Scarlet fever may be initially overlooked, especially among older children presenting with sore throat. Raising awareness among carers and practitioners may aid identification and timely treatment.
Identifiants
pubmed: 34952887
pii: bmjopen-2021-057772
doi: 10.1136/bmjopen-2021-057772
pmc: PMC9066343
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e057772Subventions
Organisme : Medical Research Council
ID : MR/P022669/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Emerg Infect Dis. 2019 Mar;25(3):529-537
pubmed: 30602121
Pediatr Infect Dis J. 2011 Apr;30(4):315-9
pubmed: 20948456
J Am Acad Dermatol. 2021 Jan;84(1):194-196
pubmed: 32335181
Br Med J. 1918 Nov 2;2(3018):486-8
pubmed: 20769242
Clin Infect Dis. 2007 Oct 1;45(7):853-62
pubmed: 17806049
Pediatrics. 2008 Feb;121(2):229-34
pubmed: 18245412
Lancet Infect Dis. 2019 Nov;19(11):1209-1218
pubmed: 31519541
Lancet Infect Dis. 2019 Nov;19(11):1154-1155
pubmed: 31519542
Br J Dermatol. 2019 Jun;180(6):1521-1522
pubmed: 31157429
J Hyg (Lond). 1928 Dec;28(3):250-66
pubmed: 20474999
JAMA. 2000 Dec 13;284(22):2912-8
pubmed: 11147989
Emerg Microbes Infect. 2012 Jul;1(7):e2
pubmed: 26038416
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
BMJ. 2013 Oct 10;347:f5806
pubmed: 24114306
Clin Infect Dis. 2012 Nov 15;55(10):1279-82
pubmed: 23091044
Microb Genom. 2016 Jun 24;2(6):e000059
pubmed: 28348855
J Am Acad Dermatol. 2006 Oct;55(4):687-90
pubmed: 17010750
JAMA. 2004 Apr 7;291(13):1587-95
pubmed: 15069046
Lancet Infect Dis. 2018 Feb;18(2):180-187
pubmed: 29191628
Euro Surveill. 2014 Mar 27;19(12):20749
pubmed: 24698137
JAMA. 1993 Jan 20;269(3):384-9
pubmed: 8418346
JAMA. 1993 Jan 20;269(3):390-1
pubmed: 8418347
Proc R Soc Med. 1932 May;25(7):927-44
pubmed: 19988768
Br J Gen Pract. 2017 Jan;67(654):e29-e40
pubmed: 27993900
Br J Gen Pract. 2018 Sep;68(674):404-405
pubmed: 29970395
BMC Genomics. 2017 Mar 10;18(1):224
pubmed: 28283023
J Paediatr Child Health. 2010 Sep;46(9):527-33
pubmed: 20854325